Phase I-II clinical and pharmacokinetic study of irofulven in combination with oxaliplatin in patients with advanced solid tumours.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Irofulven (Primary) ; Oxaliplatin (Primary)
- Indications Endometrial cancer; Gastric cancer; Liver cancer; Pancreatic cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 31 Aug 2018 Biomarkers information updated
- 09 Mar 2009 Planned end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 06 Mar 2009 Additional lead trial centre identified as reported by ClinicalTrials.gov, last updated 6 Mar 2009.